Physician profile
Gena E Leatzow
NPI 1174001747
$3,182.11
in general payments reported to CMS, 2019-2025
12 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $538 · 2023: $767 · 2024: $814 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,334 · Long Term Medical Supply Or Device Loan: $252 · Education: $57.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,333.57 |
| Long Term Medical Supply Or Device Loan | $252.31 |
| Education | $57.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $905.81 | 2022-2025 | |
| Optinose US, INC. | $778.75 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $509.25 | 2022-2025 | Dupixent, Libtayo |
| Integra Lifesciences Corporation | $316.29 | 2022-2025 | Integra, Micromatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $205.76 | 2024 | Propel, Pteye Parathyroid Detection System |
| Stryker Corporation | $111.31 | 2023-2025 | Audion Et Dilation System, Scopis Ent, Xpress Ent Dilation System |
| Alk-Abello, INC | $102.73 | 2022-2024 | Grastek, Ragwitek, Odactra |
| Glaxosmithkline, LLC. | $72.11 | 2023-2025 | Nucala |
| Aerin Medical INC. | $57.81 | 2024 | |
| Paratek Pharmaceuticals, INC. | $46.39 | 2025 | Xhance, Nuzyra |
| Merck Sharp & Dohme LLC | $39.68 | 2023-2025 | Keytruda, Keytruda Qlex |
| Inspire Medical Systems, INC. | $36.22 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gena Leatzow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.